Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T11:42:29.641Z.
Calculation as of: 2026-10-06T11:42:29.641Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b1e589d4888711efc6e495fe73fbc3b606428562d81b06b8c422d1cee3adbcc2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Establishment Labs Holdings Inc.
Market Cap
$1.96B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.01B
EV/EBIT Ratio
268.77x
TTM Avg
247.10x
3Y Avg
123.52x
5Y Avg
99.39x
Market Cap
$2.02B
EV/EBIT Ratio
12.62x
TTM Avg
22.52x
3Y Avg
26.44x
5Y Avg
26.44x
Market Cap
$1.89B
EV/EBIT Ratio
251.96x
TTM Avg
240.22x
3Y Avg
240.22x
5Y Avg
240.22x
Market Cap
$2.05B
EV/EBIT Ratio
35.97x
TTM Avg
44.12x
3Y Avg
112.76x
5Y Avg
112.76x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Establishment Labs Holdings Inc. (ESTA) | $1.96B | N/A | N/A | N/A | N/A |
| Absci Corporation (ABSI)vs › | $1.95B | N/A | N/A | N/A | N/A |
| Azenta, Inc. (AZTA)vs › | $1.97B | N/A | 227.18x | 114.14x | 99.57x |
| AxoGen, Inc. (AXGN)vs › | $2.00B | N/A | 408.25x | 408.25x | 408.25x |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | 268.77x | 247.10x | 123.52x | 99.39x |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 12.62x | 22.52x | 26.44x | 26.44x |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 251.96x | 240.22x | 240.22x | 240.22x |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.05B | 35.97x | 44.12x | 112.76x | 112.76x |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | N/A | N/A | N/A | N/A |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.06B | N/A | 41.80x | 41.80x | 41.80x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
